Overview

Co-Administration Of Methotrexate And CP-690,550

Status:
Completed

Trial end date:
2006-06-01

Target enrollment:

Participant gender:

Summary

This study was designed to estimate the effects of methotrexate (MTX) on the pharmacokinetics (PK) of CP-690,550 when administered to subjects with rheumatoid arthritis (RA), to estimate the effects of CP-690,550 on the PK of MTX and to evaluate the short-term safety and tolerability of co-administration of CP-690,550 and MTX.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Methotrexate
Tofacitinib